Wert202020212022202320242025TTMMittelzufluss aus Investitionstätigkeit-121.72 M495.41 M-1.05 B-165.8 M755.56 M69.64 M69.64 MZahlungsströme aus der Finanzierungstätigkeit682.32 M561.57 M232.51 M125 M124.81 M-168.34 M-168.34 MFreier Cashflow25.26 M-481.66 M-356.17 M-588.34 M-352.74 M-315.33 M-315.33 M
Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.